While physicians clearly need better guidance when prescribing highly addictive pain medications, many of the recommendations in new draft guidelines developed by the U.S. Centers for Disease Control and Prevention are not supported by affirmative clinical evidence, says the American Academy of Pain Management. Nor does the guidance address reimbursement issues that may hinder pat... Read More